Literature DB >> 23312620

Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.

Aya Miura1, Satoshi Akagi, Kazufumi Nakamura, Keiko Ohta-Ogo, Katsushi Hashimoto, Satoshi Nagase, Kunihisa Kohno, Kengo Kusano, Aiko Ogawa, Hiromi Matsubara, Shinichi Toyooka, Takahiro Oto, Aiji Ohtsuka, Tohru Ohe, Hiroshi Ito.   

Abstract

BACKGROUND: Centrilobular ground-glass opacity (GGO) is one of the characteristic findings in chest high-resolution computed tomography (HRCT) of patients with pulmonary veno-occlusive disease (PVOD) and patients with pulmonary capillary hemangiomatosis (PCH). However, clinical differential diagnosis of these two diseases is difficult and has not been established. In order to clarify their differences, we compared the sizes of GGOs in chest HRCT and the sizes of capillary assemblies in pulmonary vascular casts between patients diagnosed pathologically with PVOD and PCH.
METHODS: We evaluated chest HRCT images for four patients with idiopathic pulmonary arterial hypertension (IPAH), three patients with PVOD and three patients with PCH, and we evaluated pulmonary vascular casts of lung tissues obtained from those patients at lung transplantation or autopsy.
RESULTS: Centrilobular GGOs in chest HRCT were observed in patients with PVOD and patients with PCH but not in patients with IPAH. We measured the longest diameter of the GGOs. The size of centrilobular GGOs was significantly larger in patients with PCH than in patients with PVOD (5.60±1.43 mm versus 2.51±0.79 mm, P<.01). We succeeded in visualization of the 3-dimensional structures of pulmonary capillary vessels obtained from the same patients with PVOD and PCH undergoing lung transplantation or autopsy and measured the diameters of capillary assemblies. The longest diameter of capillary assemblies was also significantly larger in patients with PCH than in patients with PVOD (5.44±1.71 mm versus 3.07±1.07 mm, P<.01).
CONCLUSION: Measurement of the sizes of centrilobular GGOs in HRCT is a simple and useful method for clinical differential diagnosis of PVOD and PCH.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Centrilobular ground-glass opacity; Computed tomography; Pulmonary capillary hemangiomatosis; Pulmonary hypertension; Pulmonary veno-occlusive disease

Mesh:

Year:  2013        PMID: 23312620     DOI: 10.1016/j.carpath.2012.12.002

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  8 in total

1.  Characteristics of patients with pulmonary venoocclusive disease awaiting transplantation.

Authors:  Keith M Wille; Nirmal S Sharma; Tejaswini Kulkarni; Matthew R Lammi; Joseph B Barney; S Christopher Bellot; Ryan S Cantor; David C Naftel; Enrique Diaz-Guzman; David C McGiffin
Journal:  Ann Am Thorac Soc       Date:  2014-11

2.  Features of radiological and physiological findings in pulmonary capillary hemangiomatosis: an updated pooled analysis of confirmed diagnostic cases.

Authors:  Rie Anazawa; Jiro Terada; Seiichiro Sakao; Ayako Shigeta; Nobuhiro Tanabe; Koichiro Tatsumi
Journal:  Pulm Circ       Date:  2019-12-27       Impact factor: 3.017

3.  Clinical characteristics and prognosis of ground-glass opacity nodules in young patients.

Authors:  Jun Wang; Han Ma; Chong-Jun Ni; Jing-Kang He; Hai-Tao Ma; Jin-Feng Ge
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Vasoproliferative process resembling pulmonary capillary hemangiomatosis in a cat.

Authors:  J A Jaffey; K J Williams; I Masseau; M Krueger; C Reinero
Journal:  BMC Vet Res       Date:  2017-03-20       Impact factor: 2.741

Review 5.  A review of imaging modalities in pulmonary hypertension.

Authors:  Mona Ascha; Rahul D Renapurkar; Adriano R Tonelli
Journal:  Ann Thorac Med       Date:  2017 Apr-Jun       Impact factor: 2.219

6.  Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Authors:  Carol R Reinero; L Ari Jutkowitz; Nathan Nelson; Isabelle Masseau; Samuel Jennings; Kurt Williams
Journal:  J Vet Intern Med       Date:  2018-11-29       Impact factor: 3.333

7.  EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI).

Authors:  David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift
Journal:  Pulm Circ       Date:  2019-03-18       Impact factor: 3.017

8.  Comparison of Clinical and Pathological Characteristics Between Extremely Multiple GGNs and Single GGNs.

Authors:  Xin Wang; Manqi Wu; Haifeng Shen; Yuntao Nie; Kai Zhang; Zihan Wei; Ziyang Wang; Fan Yang; Kezhong Chen
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.